13F-HR/A filed by PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC filed this 13F-HR/A for the quarter ended 2021-03-31, filed 2021-06-10, with 139 holding rows worth $7,928,028,000.
- Accession
- 0001012975-21-000242
- Filer
- CIK 1224962
- Filed
- 2021-06-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, amendment of type new holdings, 139 entries on the cover page, a total value of $7,928,028,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $7,928,028,000 with VALUE read as thousands by filing date, 13F file number 028-10438. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 3,474,505 | $595,183,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 7,756,928 | $477,827,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 45,000,000 | $474,750,000 | thousands by filing date | principal |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 4,849,912 | $356,808,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 8,651,785 | $273,915,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 22,861,329 | $225,870,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 748,000 | $209,253,000 | thousands by filing date | call |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 5,058,642 | $206,139,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 5,360,673 | $204,831,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459JAA2 | NOTE 2.625% 2/1 | 17,500,000 | $189,560,000 | thousands by filing date | principal |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 2,050,002 | $188,682,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 3,109,224 | $184,693,000 | thousands by filing date | |
| VBI VACCINES INC | 91822J103 | COM NEW | 55,042,465 | $171,182,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 600,000 | $167,850,000 | thousands by filing date | put |
| LANDOS BIOPHARMA INC | 515069102 | CMN | 17,960,839 | $159,688,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 4,330,868 | $136,769,000 | thousands by filing date | |
| NEVRO CORP | 64157FAC7 | NOTE 2.750% 4/0 | 9,000,000 | $135,324,000 | thousands by filing date | principal |
| OUTSET MEDICAL INC | 690145107 | COM | 2,387,535 | $129,858,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 2,867,771 | $127,243,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 3,158,566 | $116,835,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 812,154 | $113,295,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 8,703,879 | $103,402,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 6,933,277 | $93,374,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 941,832 | $91,593,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 2,360,139 | $83,195,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 3,298,419 | $82,362,000 | thousands by filing date | |
| KRONOS BIO INC | 50107A104 | COM | 2,780,097 | $79,671,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 13,412,552 | $74,171,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 2,018,097 | $69,766,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 4,697,612 | $68,632,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 2,148,060 | $68,416,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 4,643,095 | $63,749,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 3,425,916 | $63,037,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 987,287 | $61,735,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 15,711,334 | $61,117,000 | thousands by filing date | |
| INARI MED INC | 45332Y109 | COM | 565,113 | $60,467,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 16,200,818 | $59,619,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 938,140 | $59,365,000 | thousands by filing date | |
| ATHENEX INC | 04685N103 | COM | 13,532,467 | $57,330,000 | thousands by filing date | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 3,314,032 | $55,354,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 2,477,481 | $55,000,000 | thousands by filing date | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 3,610,412 | $54,698,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 3,659,381 | $51,606,000 | thousands by filing date | |
| Veru Inc | 92536C103 | Common Stock | 4,451,342 | $47,963,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 353,523 | $46,587,000 | thousands by filing date | |
| VYNE THERAP. | 92941V209 | COM | 6,773,954 | $46,368,000 | thousands by filing date | |
| KODIAK SCIENCES INC | 50015M109 | COM | 389,008 | $44,110,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,296,416 | $41,127,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 7,695,505 | $41,017,000 | thousands by filing date | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 1,143,790 | $40,376,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 575,007 | $39,900,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 537,635 | $37,832,000 | thousands by filing date | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 3,222,560 | $37,349,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 1,410,305 | $36,386,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 1,250,000 | $35,025,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 15,919,925 | $33,113,000 | thousands by filing date | |
| PROVENTION BIO INC | 74374N102 | COM | 2,852,058 | $29,932,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 797,404 | $29,360,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 175,000 | $29,272,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 16,584,802 | $29,189,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 3,041,004 | $29,041,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 4,585,512 | $28,338,000 | thousands by filing date | |
| IMMATICS N.V | N44445109 | SHS | 2,500,000 | $28,025,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 3,188,750 | $27,997,000 | thousands by filing date | |
| ONCORUS INC | 68236R103 | COM | 1,989,987 | $27,700,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 409,341 | $27,143,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 671,978 | $26,100,000 | thousands by filing date | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 1,800,180 | $25,490,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 746,557 | $24,554,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 2,888,889 | $24,151,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 1,099,028 | $23,970,000 | thousands by filing date | |
| HEALTH CATALYST INC | 42225T107 | COM | 506,084 | $23,670,000 | thousands by filing date | |
| FORTE BIOSCIENCES INC | 34962G109 | COM | 685,000 | $23,475,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 978,277 | $23,185,000 | thousands by filing date | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 1,950,167 | $20,905,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 800,000 | $20,456,000 | thousands by filing date | |
| 1LIFE HEALTHCARE INC | 68269G107 | COM | 519,844 | $20,315,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 6,000,000 | $20,220,000 | thousands by filing date | |
| FREQUENCY THERAPEUTICS INC | 35803L108 | COM | 2,113,661 | $20,080,000 | thousands by filing date | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 444,878 | $19,298,000 | thousands by filing date | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 340,100 | $17,226,000 | thousands by filing date | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 400,000 | $17,028,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 850,000 | $16,787,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 2,153,974 | $16,650,000 | thousands by filing date | |
| NEPTUNE WELLNESS SOLUTIONS I | 64079L105 | COM | 12,849,706 | $16,555,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 650,000 | $16,380,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 8,476,496 | $16,105,000 | thousands by filing date | |
| CM LIFE SCIENCES II INC | 125842203 | UNIT 02/25/2028 | 1,250,000 | $16,000,000 | thousands by filing date | |
| NANOBIOTIX | 63009J107 | SPONSORED ADS | 1,059,800 | $15,939,000 | thousands by filing date | |
| THERAPEUTICS ACQUISITION COR | 88339T103 | COM CL A | 1,500,000 | $15,765,000 | thousands by filing date | |
| ACCOLADE INC | 00437E102 | COM | 345,741 | $15,686,000 | thousands by filing date | |
| HEALTHCOR CATALIO ACQU CORP | G44125105 | CL A SHS | 1,500,000 | $14,880,000 | thousands by filing date | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 352,804 | $14,204,000 | thousands by filing date | |
| VIATRIS INC COM | 92556V106 | Stock | 1,004,419 | $14,032,000 | thousands by filing date | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 755,375 | $12,501,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 2,150,641 | $10,731,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 1,000,000 | $10,570,000 | thousands by filing date | |
| CLOVER HEALTH INVESTMENTS CO | 18914F103 | COMMON STOCK | 1,500,000 | $10,322,000 | thousands by filing date | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 311,673 | $10,298,000 | thousands by filing date | |
| RESEARCH ALLIANCE CORP II | 760873109 | CMN | 1,000,000 | $10,250,000 | thousands by filing date | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 470,440 | $9,548,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 515,042 | $9,219,000 | thousands by filing date | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 787,745 | $7,523,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P206 | COM NEW | 2,476,924 | $7,158,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 200,000 | $6,942,000 | thousands by filing date | put |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 313,300 | $6,918,000 | thousands by filing date | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 421,642 | $6,637,000 | thousands by filing date | |
| DARIOHEALTH CORP | 23725P209 | COM | 327,869 | $6,314,000 | thousands by filing date | |
| AMERICAN WELL CORP | 03044L105 | CL A | 355,000 | $6,166,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 270,000 | $6,037,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 300,000 | $5,790,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 500,000 | $5,560,000 | thousands by filing date | |
| PHREESIA INC | 71944F106 | COM | 100,000 | $5,210,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 450,000 | $5,036,000 | thousands by filing date | |
| LONGVIEW ACQUISITION CORP II | 54319Q204 | UNIT 99/99/9999 | 500,000 | $5,020,000 | thousands by filing date | |
| CONSONANCE HFW ACQUISITION C | G2445M129 | UNIT 99/99/9999 | 500,000 | $4,880,000 | thousands by filing date | |
| DEERFIELD HEALTHCARE TECH AC | 244413209 | UNIT 07/16/2025 | 300,000 | $3,930,000 | thousands by filing date | |
| THERAPEUTICSMD INC | 88338N107 | COM | 2,750,000 | $3,685,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 175,000 | $3,655,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 751,748 | $3,270,000 | thousands by filing date | |
| TALIS BIOMEDICAL CORP | 87424L108 | CMN | 250,000 | $3,212,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 300,000 | $3,042,000 | thousands by filing date | |
| SIGILON THERAPEUTICS INC | 82657L107 | COM | 125,000 | $2,794,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 69,283 | $2,363,000 | thousands by filing date | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 254,664 | $2,246,000 | thousands by filing date | |
| MOTUS GI HLDGS INC | 62014P108 | COM | 1,800,542 | $2,070,000 | thousands by filing date | |
| PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/23 | 72942A107 | COMMON STOCK | 222,180 | $2,006,000 | thousands by filing date | |
| CM LIFE SCIENCES INC | 18978W109 | COM CL A | 127,000 | $1,891,000 | thousands by filing date | |
| BUTTERFLY NETWORK INC | 124155110 | *W EXP 02/12/202 | 233,333 | $1,505,000 | thousands by filing date | |
| FERRARI N V | N3167Y103 | COM | 6,200 | $1,298,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 139,890 | $1,238,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L114 | *W EXP 12/24/202 | 300,000 | $1,212,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 66,655 | $1,148,000 | thousands by filing date | |
| SC HEALTH CORP | G78516401 | *W EXP 99/99/999 | 500,000 | $945,000 | thousands by filing date | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 27,000 | $755,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U102 | *W EXP 06/09/202 | 133,066 | $573,000 | thousands by filing date | |
| CEL-SCI CORP | 150837607 | COM PAR NEW | 33,700 | $513,000 | thousands by filing date | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 10,000 | $335,000 | thousands by filing date | |
| DEERFIELD HEALTHCARE TECH AC | 244413100 | COM CL A | 20,000 | $242,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-21-000229 | superseded | 2021-05-17 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001012975-21-000242 | this filing | 2021-06-10 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001012975-21-000299 | base | 2021-08-13 | acceptance time not in the bulk data set |